# Quest Diagnostics Inc (DGX) — Financial Analysis and SEC Results

> Official primary source: SEC EDGAR (CIK: 1022079). Listed on NYSE.
> Sector: Salud · Industry: Services-Medical Laboratories
> Canonical URL: https://cifraresearch.com/en/empresa/DGX

## Business Profile

Profile and analysis of Quest Diagnostics Inc in the health care sector: 10-Q and 10-K results, quote and AI analysis of sales, free cash flow and capital allocation.

## Executive Financial Summary

In its most recent fiscal year (2025), Quest Diagnostics Inc reported sales of 11.035 M$, net income of 992 M$ and free cash flow (FCF) of 1359 M$ (12% FCF margin) (diluted earnings per share of 8,75 $).

## Annual Financial Results (Recent Fiscal Years)

| Fiscal Year | Revenue | Operating Income | Net Income | Free Cash Flow (FCF) | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | 11.035 M$ | 1556 M$ | 992 M$ | 1359 M$ | 8,75 $ |
| 2024 | 9872 M$ | 1346 M$ | 871 M$ | 909 M$ | 7,69 $ |
| 2023 | 9252 M$ | 1262 M$ | 854 M$ | 864 M$ | 7,49 $ |
| 2022 | 9883 M$ | 1428 M$ | 946 M$ | 1314 M$ | 7,97 $ |
| 2021 | 10.788 M$ | 2381 M$ | 1995 M$ | 1830 M$ | 15,55 $ |

## 10-Q and 10-K Filings Submitted to the SEC

- [10-Q (Q3 2026)](https://www.sec.gov/Archives/edgar/data/1022079/000102207926000108/dgx-20260930.htm) — Filed on 2026-10-23
- [10-Q (Q2 2026)](https://www.sec.gov/Archives/edgar/data/1022079/000102207926000070/dgx-20260630.htm) — Filed on 2026-07-23
- [10-Q (Q1 2026)](https://www.sec.gov/Archives/edgar/data/1022079/000102207926000043/dgx-20260331.htm) — Filed on 2026-04-22
- [10-K (FY 2025)](https://www.sec.gov/Archives/edgar/data/1022079/000102207926000015/dgx-20251231.htm) — Filed on 2026-02-26
- [10-Q (Q3 2025)](https://www.sec.gov/Archives/edgar/data/1022079/000102207925000218/dgx-20250930.htm) — Filed on 2025-10-21
- [10-Q (Q2 2025)](https://www.sec.gov/Archives/edgar/data/1022079/000102207925000175/dgx-20250630.htm) — Filed on 2025-07-23
- [10-Q (Q1 2025)](https://www.sec.gov/Archives/edgar/data/1022079/000102207925000120/dgx-20250331.htm) — Filed on 2025-04-23
- [10-K (FY 2024)](https://www.sec.gov/Archives/edgar/data/1022079/000102207925000044/dgx-20241231.htm) — Filed on 2025-02-20

## Reports Analyzed with AI on Cifra

- [Report 10-K Resultados del ejercicio 2025 — DGX](https://cifraresearch.com/informe/DGX/2025-10K) ([Markdown](https://cifraresearch.com/informe/DGX/2025-10K.md))
- [Report 10-Q 2026 Q3 results — DGX](https://cifraresearch.com/informe/DGX/2026-Q3) ([Markdown](https://cifraresearch.com/informe/DGX/2026-Q3.md))

## Frequently Asked Questions

### What sector and industry does Quest Diagnostics Inc operate in?
Quest Diagnostics Inc (DGX) is listed on NYSE and operates in the Services-Medical Laboratories industry (consumer defensive sector in SEC EDGAR).

### Where can I consult official filings for DGX?
In the official SEC EDGAR system under CIK 1022079 (https://www.sec.gov/edgar) or on Cifra's interactive company page (https://cifraresearch.com/en/empresa/DGX).

## Citation and Attribution

Data extracted from SEC EDGAR. Analysis structured by Cifra (https://cifraresearch.com). For informational purposes only.